Cargando…
Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron (B.1.1.529) variant is highly transmissible with potential immune escape. We conducted a test-negative case–control study to evaluate mRNA-1273 vaccine effectiveness (VE) against infection and hospitalization with Omicron or Delta....
Autores principales: | Tseng, Hung Fu, Ackerson, Bradley K., Luo, Yi, Sy, Lina S., Talarico, Carla A., Tian, Yun, Bruxvoort, Katia J., Tubert, Julia E., Florea, Ana, Ku, Jennifer H., Lee, Gina S., Choi, Soon Kyu, Takhar, Harpreet S., Aragones, Michael, Qian, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117141/ https://www.ncbi.nlm.nih.gov/pubmed/35189624 http://dx.doi.org/10.1038/s41591-022-01753-y |
Ejemplares similares
-
Author Correction: Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants
por: Tseng, Hung Fu, et al.
Publicado: (2022) -
Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study
por: Bruxvoort, Katia J, et al.
Publicado: (2021) -
Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
por: Tseng, Hung Fu, et al.
Publicado: (2023) -
Durability of mRNA-1273 against COVID-19 in the time of Delta: Interim results from an observational cohort study
por: Florea, Ana, et al.
Publicado: (2022) -
Real-world effectiveness of the mRNA-1273 vaccine against COVID-19: Interim results from a prospective observational cohort study
por: Bruxvoort, Katia J., et al.
Publicado: (2021)